Eli Lilly & Co
LLY· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Revenue | $5.86B | $5.09B | $4.96B | $5.23B |
| Net Income | $1.46B | $4.24B | $1.22B | -$110.80M |
| EPS Diluted | $1.60 |
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
| $4.31 |
| $1.16 |
| -$0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.